We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Guidance Describes Pharmacology Considerations for Pediatric Drug Studies
FDA Guidance Describes Pharmacology Considerations for Pediatric Drug Studies
Drugmakers planning to submit investigational drug, new drug or biologics license applications for pediatric drug studies should conduct clinical pharmacology studies using patients with the disease the drug is intended to treat, according to a new draft guidance released by the FDA today.